We are living through the greatest acceleration in the history of medicine. Molecules are now designed in days. Discovery has gone exponential. Yet it still takes twelve years to put a single therapy in a patient's hands. Most of those years are not science.
They are operation.
Eighteen to twenty-four months can pass before a trial even begins, lost to fragmented systems, institutional amnesia, and the same questions asked of the same sites thousands of times a year. None of it is required by regulation. It is friction, and friction is a choice we can unmake.
Yendou is built to unmake it. We run the work between RFI and First Patient In as one automated system that remembers everything it does, so nothing is ever asked twice and every study moves faster than the one before.
We offer it to every CRO and every sponsor, so the cost and speed of a trial no longer depend on the size of the company running it.
Most trial software solves its own problem by handing the site another login, another portal, another form. We refuse to. Yendou is non-site-facing by design: it removes administrative and operational load from sponsor and site alike, and asks the site to adopt nothing.
“I spent twelve years making cancer drugs before I understood the bottleneck was never the molecule. It was the machinery that delivers it. I left to build that machinery, and to make it available to everyone racing the same clock.”
Zina Sarif · Founder & Chief Executive OfficerYendou raised €1.7M in pre-seed funding.
Customer stories worth borrowing. Insights worth keeping. The work that actually happens between RFI and First Patient In, direct to your inbox.
Subscribe →Tell us where Yendou can move your next bid, or your next study. We read every message.
We use essential cookies to run this site. With your consent, we also use analytics cookies to understand how the site is used and improve it. See our Cookie Policy.